Showing results (491-500 of 606) with videos related to
Sort By:
Pageof 61
JACC. Cardiovascular Interventions|September 24, 2025
1-Year Outcomes of Transfemoral Transcatheter Mitral Valve Replacement With the Eos System: The MISCEND StudyRaj Makkar, Moody M Makar, Sabah Skaf, et al.Journal of the American College of Cardiology|June 12, 2003
Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational StudyAlan S Maisel, James McCord, Richard M Nowak, et al.Circulation|November 7, 2019
Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER TrialsMatthew R Summers, Martin B Leon, Craig R Smith, et al.Journal of the American College of Cardiology|October 3, 2019
Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisSuzanne J Baron, Elizabeth A Magnuson, Michael Lu, et al.JAMA Cardiology|December 8, 2022
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular TherapiesAshwin S Nathan, Kriyana P Reddy, Lin Yang, et al.Journal of the American College of Cardiology|April 30, 2013
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves)Rebecca T Hahn, Philippe Pibarot, William J Stewart, et al.Circulation|December 28, 2018
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate RiskSuzanne J Baron, Kaijun Wang, John A House, et al.The Journal of Thoracic and Cardiovascular Surgery|May 14, 2014
The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trialNirat Beohar, Brian Whisenant, Ajay J Kirtane, et al.JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.American Heart Journal|April 29, 2006
How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational StudyLori B Daniels, Paul Clopton, Vikas Bhalla, et al.Pageof 61